Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine
- PMID: 9427251
- DOI: 10.1016/s0896-6273(00)80419-5
Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine
Abstract
Vesicular monoamine transporters are known to transport monoamines from the cytoplasm into secretory vesicles. We have used homologous recombination to generate mutant mice lacking the vesicular monoamine transporter 2 (VMAT2), the predominant form expressed in the brain. Newborn homozygotes die within a few days after birth, manifesting severely impaired monoamine storage and vesicular release. In heterozygous adult mice, extracellular striatal dopamine levels, as well as K+- and amphetamine-evoked dopamine release, are diminished. The observed changes in presynaptic homeostasis are accompanied by a pronounced supersensitivity of the mice to the locomotor effects of the dopamine agonist apomorphine, the psychostimulants cocaine and amphetamine, and ethanol. Importantly, VMAT2 heterozygous mice do not develop further sensitization to repeated cocaine administration. These observations stress the importance of VMAT2 in the maintenance of presynaptic function and suggest that these mice may provide an animal model for delineating the mechanisms of vesicular release, monoamine function, and postsynaptic sensitization associated with drug abuse.
Similar articles
-
Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.Neuron. 1997 Dec;19(6):1271-83. doi: 10.1016/s0896-6273(00)80418-3. Neuron. 1997. PMID: 9427250
-
Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.J Neurochem. 2003 May;85(4):898-910. doi: 10.1046/j.1471-4159.2003.01732.x. J Neurochem. 2003. PMID: 12716422
-
VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9938-43. doi: 10.1073/pnas.94.18.9938. Proc Natl Acad Sci U S A. 1997. PMID: 9275230 Free PMC article.
-
Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.J Exp Biol. 1994 Nov;196:251-62. doi: 10.1242/jeb.196.1.251. J Exp Biol. 1994. PMID: 7823026 Review.
-
The vesicular monoamine transporter: from chromaffin granule to brain.Neurochem Int. 1998 Mar;32(3):227-46. doi: 10.1016/s0197-0186(97)00092-2. Neurochem Int. 1998. PMID: 9587917 Review.
Cited by
-
Disruption of Transient Serotonin Accumulation by Non-Serotonin-Producing Neurons Impairs Cortical Map Development.Cell Rep. 2015 Jan 20;10(3):346-358. doi: 10.1016/j.celrep.2014.12.033. Epub 2015 Jan 15. Cell Rep. 2015. PMID: 25600870 Free PMC article.
-
A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles.J Cell Biol. 2000 Apr 17;149(2):379-96. doi: 10.1083/jcb.149.2.379. J Cell Biol. 2000. PMID: 10769030 Free PMC article.
-
A specific survival response in dopamine neurons at most risk in Parkinson's disease.J Neurosci. 2006 Sep 20;26(38):9750-60. doi: 10.1523/JNEUROSCI.2745-06.2006. J Neurosci. 2006. PMID: 16988046 Free PMC article.
-
Dopamine-deficient mice are hypersensitive to dopamine receptor agonists.J Neurosci. 2000 Jun 15;20(12):4405-13. doi: 10.1523/JNEUROSCI.20-12-04405.2000. J Neurosci. 2000. PMID: 10844009 Free PMC article.
-
VMAT2 identified as a regulator of late-stage β-cell differentiation.Nat Chem Biol. 2014 Feb;10(2):141-8. doi: 10.1038/nchembio.1410. Epub 2013 Dec 15. Nat Chem Biol. 2014. PMID: 24316738
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases